Results 171 to 180 of about 6,053 (228)

Nonarteritic Anterior Ischemic Optic Neuropathy

2011
Nonarteritic anterior ischemic optic neuropathy is the most frequent cause of optic neuropathy in older adults. Its pathogenesis remains uncertain, although it often occurs in patients with small, structurally congested optic discs. We summarize the symptoms, signs, possible precipitating factors, and management of this common optic neuropathy.
Matthew J. Thurtell, Robert L. Tomsak, Robert B. Daroff   +2 more
openaire   +2 more sources

Systemic Diseases Associated with Nonarteritic Anterior Ischemic Optic Neuropathy

Journal of Neuro-Ophthalmology, 1994
We investigated, in nonarteritic anterior ischemic optic neuropathy, the prevalence of various systemic diseases before or at its onset and the incidence of subsequent morbidity and mortality.We investigated prospectively the presence of systemic diseases before or at the onset of nonarteritic anterior ischemic optic neuropathy in 406 patients.
S S, Hayreh, K M, Joos, P A, Podhajsky, C R, Long   +3 more
openaire   +4 more sources

New Treatments for Nonarteritic Anterior Ischemic Optic Neuropathy

Neurologic Clinics, 2017
Despite increasing knowledge about the risk factors and clinical findings of nonarteritic anterior ischemic optic neuropathy (NAION), the treatment of this optic neuropathy has remained limited and without clear evidence-based benefit. Historical treatments of NAION are reviewed, beginning with the Ischemic Optic Neuropathy Decompression Trial.
Rod Foroozan
openaire   +4 more sources

Nonarteritic Anterior Ischemic Optic Neuropathy

2015
Arielle Spitze, Chris Pruet, Nagham Al-Zubidi, Andrew G. Lee   +3 more
openaire   +2 more sources

Incipient Nonarteritic Anterior Ischemic Optic Neuropathy

Ophthalmology, 2007
To describe the clinical entity of incipient nonarteritic anterior ischemic optic neuropathy (NAION).Cohort study.Fifty-four patients (60 eyes) seen in our clinic from 1973 through 2000.At their first visit to our clinic, all patients gave a detailed ophthalmic and medical history and underwent a comprehensive ophthalmic evaluation, color fundus ...
Sohan Singh, Hayreh, M Bridget, Zimmerman   +1 more
openaire   +2 more sources

Sildenafil-associated nonarteritic anterior ischemic optic neuropathy

Ophthalmology, 2002
To describe the clinical features of five patients who developed nonarteritic anterior ischemic optic neuropathy (NAION) after ingestion of sildenafil citrate (Viagra; Pfizer Pharmaceuticals, New York, NY).Retrospective observational case series.Five patients with NAION who reported the use of sildenafil citrate before the onset of ocular symptoms.The ...
Howard D, Pomeranz, Kyle H, Smith, William M, Hart, Robert A, Egan   +3 more
openaire   +2 more sources

Choroidal Thickness in Nonarteritic Anterior Ischemic Optic Neuropathy

American Journal of Ophthalmology, 2014
To examine choroidal thickness in nonarteritic anterior ischemic optic neuropathy (AION).Retrospective case control study.In the eye clinic of the University Medical Center in Mannheim, Germany, we studied a group that consisted of patients with nonarteritic AION and a control group that consisted of individuals with normal fundus.
Alexander K. Schuster, Philippe Steinmetz, Tessa M. Forster, Frank C. Schlichtenbrede, Björn C. Harder, Jost B. Jonas   +5 more
openaire   +2 more sources

Race Distribution in Nonarteritic Anterior Ischemic Optic Neuropathy

American Journal of Ophthalmology, 2023
To describe the racial distribution of patients diagnosed with nonarteritic anterior ischemic optic neuropathy (NAION) in 2 large urban academic centers in the United States.Retrospective cross-sectional study.All patients with NAION evaluated between 2014 and 2022 in tertiary neuro-ophthalmology services in Atlanta, GA, and New York, NY, respectively,
Ana, Banc, Mark, Kupersmith, Nancy J, Newman, Valérie, Biousse   +3 more
openaire   +2 more sources

Semaglutide: Nonarteritic Anterior Ischemic Optic Neuropathy in the FDA adverse event reporting system - A disproportionality analysis.

Obesity Research and Clinical Practice
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, is used for type 2 diabetes (T2D) and approved for obesity by the FDA in 2022 and in Europe in 2023.
Marina Azab, Luca Pasina
semanticscholar   +1 more source

Nonarteritic anterior ischemic optic neuropathy in young patients

Journal Français d'Ophtalmologie, 2015
To determine and report the demographic and clinical features of patients younger than 50 years with nonarteritic anterior ischemic optic neuropathy (NAION).In this comparative study, we retrospectively reviewed the medical records of 120 patients with NAION.
E B, Turkoglu, H D, Ilhan, A, Cetinkaya, A B, Bilgin, K C, Apaydin   +4 more
openaire   +2 more sources